India’s Diagnostic, Pathology Industry Seen Making Consolidation Moves
This article was originally published in PharmAsia News
Executive Summary
India's diagnostics and pathology industry is expected to begin a consolidation move as it continues growing at a rate of 10 percent to 12 percent a year. The head of an investment firm said several regional players are attempting to become the nation's first national player, but the route to get there is time-consuming and expensive. That, he said, leaves the firms with little choice but to merger with companies in similar situations. A consultant said diagnostics and pathology laboratories need to reduce their costs and could do that only by consolidating as they attempt to expand business. (Click here for more